Abstract -Aims: Ethyl glucuronide (EtG) and ethyl sulphate (EtS) are minor metabolites of ethanol, and their presence in urine provides a strong indication of recent alcohol administration. In this study, we performed a drinking experiment to investigate the kinetics of EtG and EtS formation and elimination after the administration of two doses of alcohol. Methods: Nineteen volunteers provided urine and serum (only 18) after administration of 4 and 8 units of alcohol (1 unit corresponds to 10 ml or~8 g of pure ethanol). The analysis was performed using a validated ultra-performance liquid chromatography-mass spectrometry (UPLC ® -MS/ MS) method. Results: After 4 units, the median EtG maximum concentration (C max ) was 0.4 µg/ml and the interquartile range (0.3 µg/ml) in serum and 3.5 mg/h (1.2 mg/h) in urine and were reached (T max ) after 2.0 h (0.8 h) and 3.0 h (1.0 h), respectively. EtS C max was 0.2 µg/ml (0.1 µg/ml) in serum and 1.3 mg/h (0.6 mg/h) in urine, and the corresponding T max were 1.0 h (1.0 h) and 2.0 h (0.5 h). After 8 units, EtG C max was 1.3 µg/ml (0.4 µg/ml) in serum and 10 mg/h (3.4 mg/h) in urine and was reached after 4.0 h (1.8 h) and 4.0 h (2.0 h), respectively. EtS C max was 0.6 µg/ml (0.1 µg/ml) in serum and 3.5 mg/h (1.1 mg/h) in urine, the corresponding T max were 3.0 h (1.0 h) and 3.0 h (1.0 h). The EtG/EtS ratio increased as a function of the time after alcohol administration in both serum and urine samples but to a lesser extent after 8 units than 4. Conclusion: These results correlate with values obtained in previous studies. T max of EtG and EtS increased between 4 and 8 units. The EtG:EtS ratio increased in the serum and urine samples of all volunteers as a function of time at least up to 4 h after alcohol administration.
INTRODUCTION
Ethanol is metabolized mainly in the liver to acetaldehyde and then to acetic acid, and its excretion is very rapid and the detection time in saliva, breath or blood is typically limited to <12 h and a few hours longer in urine, depending on the amount of alcohol ingested (Helander et al., 1996; Wurst et al., 2000; Ramchandani et al., 2001) .
A small amount (<0.1%) of ethanol is glucurono-or sulfoconjugated and excreted as ethyl glucuronide (EtG) and ethyl sulphate (EtS), respectively. These metabolites are detectable for longer than ethanol itself and their presence in urine provides a strong indication of recent drinking (Wurst et al., 2000 (Wurst et al., , 2003a (Wurst et al., ,b, 2006 Seidl et al., 2001; Wurst and Metzger, 2002; Helander and Beck, 2005) . Many studies have demonstrated that EtG and EtS are valuable biomarkers of ethanol intake and their analysis in body fluids is performed in many clinical and forensic investigations such as alcohol abstinence in treatment programmes and drinkdriving claims. Furthermore, in anti-doping control programmes, the detection of EtG and EtS could be useful, since there is evidence that excessive alcohol consumption may influence the urinary testosterone/epitestosterone ratio (T/E; Sarkola and Eriksson, 2003; Große et al., 2009) . The analysis of EtG and EtS in biological matrix is normally performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods (Dresen et al., 2004; Politi et al., 2005; Bicker et al., 2006; Favretto et al., 2010) .
In many situations, particularly in drink-driving claims, it is very important to know the time since ethanol was consumed. Thus, the kinetics of EtG and EtS in urine and serum has been investigated in controlled drinking experiments to evaluate their possible use to calculate the time of ethanol intake (Høiseth et al., 2007 (Høiseth et al., , 2010 Halter et al., 2008) . With the data available, a group in Germany has developed computer-assisted models to simulate EtG and EtS serum concentration versus times curves to calculate the time of ethanol intake (Droenner et al., 2002; Schmitt et al., 2010) . In the previous studies, small numbers of volunteers (10-13) were enrolled to participate in drinking experiments, only one dose of alcohol was administered (one study administered two different amounts of ethanol) and a small number of time-points used for sample collection, providing a limited description of the kinetics of EtG and EtS. Furthermore, EtG and EtS were not always analysed in both urine and serum samples.
For these reasons, we measured EtG and EtS in serum and urine of healthy volunteers after they consumed two different doses of alcohol in separate controlled drinking experiments. The aim of the study was to obtain a more accurate and comprehensive description of EtG and EtS concentration-time profiles in biological matrices. Furthermore, we also wanted to investigate how glucuronidation and sulphation metabolic pathways are affected by different concentrations of ethanol ingested.
MATERIALS AND METHODS

Reagents and calibrators
HPLC grade acetonitrile and formic acid were purchased from Fisher Scientific (Loughborough, UK) and VWR (Paris, France), respectively. Ultrapure water was prepared by ultrafiltration of deionized water with Purelab Maxima Scientific system (Pocklington, UK).
EtG and D5-EtG were purchased from Medichem (Steinenbronn, Germany), EtS was purchased from TCI Europe (Oxford, UK) and D5-EtS was synthesized following the procedure published by Dresen et al. (2004) . Creatinine was purchased from Sigma-Aldrich; D3-Creatinine was kindly provided by Dr Dalton (St Thomas Hospital, London, UK).
Stock solutions were prepared in methanol at concentrations of 1000 µg/ml for both EtG and EtS.
Standards were prepared in alcohol-free urine at 10, 5, 3, 2, 1 and 0.5 µg/ml. Quality controls (QCs) were prepared in alcohol-free urine at 0.5, 3 and 10 µg/ml.
Alcohol-free serum standards were prepared at 3, 1, 0.5, 0.15 and 0.05 µg/ml, while the QCs were 0.05, 0.3 and 2 µg/ ml.
Creatinine stock solution was prepared in purified water at 1000 µg/ml and serial dilutions in water were made to obtain the following concentrations: 500, 100, 50, 10 and 5 μg/ml. QCs were prepared in water at 5, 50 and 300 μg/ml.
Deuterated internal standards (IS) were used for the analysis of the respective analytes. A 100 µg/ml stock solution of D5-EtG in purified water was made, while D5-EtS stock was obtained by a dilution of 1:1000 in water (solution A) of the synthesized solution. The IS working solution was 5 µg/ml for D5-EtG and prepared by diluting solution A 1:100 for D5-EtS.
D3-creatinine stock solution was 1 mg/ml in 0.02 M HCl and the working solution was 10 μg/ml in purified water.
Study design
The protocol was approved by the National Research Ethics Service in the UK (approval number: 10/H0805/024) and all the participants gave informed consent.
Nineteen healthy volunteers (9:10 male: female, non-Asian, 18-35 years old and with a body weight between 50 and 80 kg) participated in two separate controlled drinking experiments, with at least 1 week interval in between, and provided blood and urine samples.
At least 1week before the first experiment, for each volunteer, a blood sample (10 ml) was collected and analysed to monitor liver function and blood coagulation time.
The exclusion criteria were altered values for liver function or haematological examinations, history of alcoholism, hepatic and/or kidney failure, hormonal disturbances, psychiatric disorders, pregnancy or breastfeeding or on any regular medication. Asians were excluded since 40% cannot metabolize acetaldehyde rapidly, and thus the administration of even low to medium doses of alcohol could cause toxic effects. Participants who were below or above the weight limit of 50-80 kg were also excluded, since we needed the volunteers to reach a minimum blood alcohol concentration or we did not wish to intoxicate them.
For each drinking experiment, volunteers abstained from alcohol during the 3 days before the study, according to selfreporting and confirmation by analysis of EtG and EtS in urine, and for 3 days after alcohol administration. The participants were asked to have a light breakfast (non-cooked) on the morning of the study and they signed in for the study at 10 a.m. An intravenous cannula was inserted and 10 ml of blood and a urine sample was collected, in Vacutainer tubes for serum collection, before the start of drinking.
In the first experiment, 4 units of alcohol (corresponding to a mean value of 0.76 g of ethanol/kg of body weight, calculated by the Widmark equation; Widmark factors used: 0.68 for males and 0.55 for females) was administered in the form of 100 ml of vodka 40% (v/v) diluted in 300 ml of orange juice or tonic water. In the second experiment, 8 units of alcohol (corresponding to a mean value of 1.53 g/ kg) was administered in the form of 200 ml of vodka 40% (v/v) diluted in 300 ml of orange juice or tonic water.
Ethanol was consumed at lunch time (12 a.m.) over a 60-min period (for 4 units, volunteers had to drink 100 ml of alcoholic drink every 15 min over a total period of 60 min, while for 8 units they drank 125 ml every 15 min). Ethanol in serum was measured using a standardized gas chromatography-flame ionization detection method in use in the clinical practice of St Thomas Hospital of London. The serum alcohol measurements showed an average C max of 386 µg/ml (T max, 1 h) after 4 units and a C max of 1050 µg/ml (T max is 1 h) after 8 units.
A standardized light lunch, ham and cheese ( protein 13.9 g, carbohydrates 2.9 g, total sugars 2.6 g, fats 8.9 g, saturated fats 5.4 g, mono-unsaturated fats 2.7 g, poly-unsaturated fats 0.3 g and fibre 1.2 g) or vegetarian sandwiches ( protein 12.9 g, carbohydrates 2.6 g, total sugars 2.5 g, fats 15.6 g, saturated fats 10 g, mono-unsaturated fats 4.2 g, polyunsaturated fats 0.6 g and fibre 1.1 g), was provided during the ethanol consumption period and water intake was permitted without limitation. After lunch, the volunteers were allowed to drink a fixed volume of water (125 ml) every hour for the following 6 h.
Urine samples were collected after alcohol administration every hour for the first 7 h and then after 10, 24, 48 and 72 h. The volunteers collected the 7-and 10-h urine samples after leaving the unit. The volunteers came back to the unit during the following 3 days to collect the 24-, 48-and 72-h urine samples. For each sample, all the urine volume was quantitatively collected, measured and then 50 ml aliquots were immediately stored at −20°C until analysis.
Blood samples of 15 ml were collected every hour for the first 6 h and then after 24 and 48 h. The intravenous cannula was flushed with 0.9% NaCl before each sample collection between the first six samples. The volunteers came back to the unit to collect the 24-and 48-h blood samples. After collection, the blood was allowed to stand for 30 min and then centrifuged at 1000g for 10 min to isolate the serum fraction, which was immediately stored at −20°C.
At the end of each drinking experiment, before the volunteers were allowed to leave the unit, a breath-test was performed to monitor the alcohol concentration and they were asked to stay in until an alcohol level below 35 μg/dl was reached in the breath-test (the driving limit in UK).
Sample preparation
EtG and EtS were analysed in urine and serum samples, while creatinine was measured only in urine.
EtG and EtS urine samples were diluted 10 times with the LC mobile phase (99% formic acid 0.1%/1% acetonitrile). Briefly, the samples were centrifuged at 10,000g for 5 min to remove sediments, then 100 µl was mixed with 100 µl of IS working solution and 800 µl of mobile phase added. Twenty microlitres was injected into the LC-MS/MS system. For serum analysis, 100 µl of sample was mixed with 100 µl of IS and 800 µl of acetonitrile added to precipitate proteins. The samples were centrifuged at 14,000 g for 5 min and 900 µl of supernatant was collected and dried. The samples were then resuspended in 180 µl of mobile phase and 20 µl injected for the analysis.
For creatinine analysis, the standards and QCs were diluted 100 times, while the urine samples 400 times. Briefly, 10 µl of sample was mixed with 10 µl of IS working solution and then 980 µl of mobile phase added. Then, only for the urine samples, 100 µl was further mixed with 300 µl of mobile phase. Five microlitres was injected into the LC-MS/MS system.
LC-MS/MS analysis
The mass spectrometer was an API 3200 triple quadrupole (Applied Biosystems, USA) coupled with an Acquity UltraPerformance Liquid Chromatography (UPLC ® ) system (Waters) and interfaced with a Turbo Spray ion source operated at 480°C. The column was a 150 × 2 mm, Synergi RP-Polar 4 μm 80 Å (Phenomenex, USA). Solvent A was 0.1% formic acid and solvent B 100% acetonitrile.
EtG and EtS were separated with a flow-rate of 200 μl/min using the following gradient: 1% solvent B for 4 min; 80% solvent B for 1 min; re-equilibration with solvent A for 2.5 min. The electrospray ionization (ESI) was in negative mode for both analytes, with an Ion Spray Voltage of −4500 eV and the instrument operated in selective reaction monitoring (SRM) mode. The MS/MS acquisition was divided in two periods in order to have a cycle time of <1 s for each analyte-IS pair. The first period (3.2 min) was specific to EtS and D5-EtS, and then to EtG and its IS. For EtG quantification, the precursor/product ion pair m/z 221/85 was used as quantifier, while the pair at m/z 125/80 was used for EtS.
Creatinine was eluted at a flow rate of 200 μl/min with the following gradient: 1% solvent B for 2.5 min; 70% solvent B for 1 min; then re-equilibration with solvent A for 3 min. Ionization was in positive mode, Ion Spray Voltage of 4500 eV and the instrument operated in SRM mode. Creatinine was quantified using the ion pair m/z 114/44.
Analytical validation
The LC-MS/MS methods were validated in accordance with the guidelines of the Drug Control Centre, which is accredited by the World Anti-Doping Agency and to ISO 17025 for drug testing analysis. Full validation included linearity, limit of detection (LOD), lower limit of quantification (LLOQ), recovery, within-day and between-day precision and accuracy.
The linearity of calibration curves was established by injecting standard mixtures of different known concentrations in matrix (serum and urine). The range was considered linear if the regression coefficient (r 2 ) obtained by a linear regression analysis was greater than 0.995 and the error profile showed an accuracy within 10% of the calculated line. LOD was defined as the lowest detectable amount of analyte that gave a signal-to-noise ratio of 3. The LLOQ was defined as the lowest concentrations of analyte that could be determined with a precision and accuracy of less than ± 20% and with a minimum signal-to-noise ratio of 10:1.
Accuracy and precision of the method were assessed by analysing 10 replicates of each QC sample (urine and serum) over three consecutive days. The accuracy and precision had to be less than ± 10% of each nominal value for both withinand between-day tests.
Recovery was calculated by spiking urine and serum samples with three different concentrations (1, 5 and 8 µg/ml final concentrations in urine; 0.1, 0.5 and 2 µg/ml final concentrations in serum) of EtG and EtS and was calculated as follows: [(final concentration−initial concentration)/added concentration] × 100. This should be within the range ±15%.
Data analysis
Statistical analyses were carried out using the software SPSS version 9.0 (SPSS Inc., Chicago, IL, USA). Data are presented as median and interquartile range (IQR) and the results were statistically treated by using a general linear model with repeated measures. Statistical significance was expressed as P < 0.05.
The kinetic parameters considered were maximum concentration (C max ) and the time when C max was reached (T max ) for EtG and EtS in urine and serum. The area under the curve (AUC) was calculated using the trapezoidal rule. EtG and EtS urinary concentrations were normalized versus the urine volumes and also against creatinine concentrations.
RESULTS
LC-MS/MS analysis
EtS and EtG were eluted at 2.5 and 3.5 min, respectively, with a high aqueous composition (99%), but we found that this did not affect the stability of the ionization process into the ESI source. We also tested the presence of possible interferences, finding no peak coelution with other compounds.
Identification was performed by monitoring four ion transitions for EtG (m/z 221/85, 221/75, 221/113, 221/203) and two for EtS (m/z 125/80, 125/97).
Linear responses were observed in the range 0-60 µg/ml in urine and up to 20 µg/ml in serum for both EtG and EtS. The regression coefficient (r 2 ) was always greater than 0.995 and the standards within 10% of the calculated line. Every time a urine sample had a concentration (for one or both of the analytes) greater than 60 µg/ml, an additional dilution (in mobile phase) of the same sample aliquot was performed in order to bring the concentration within the linear range of the calibration curve. We found (data not shown) that the recovery was not affected by the additional dilutions.
The LLOQ in urine was 0.15 µg/ml for EtG and 0.1 µg/ml for EtS, while in serum it was 0.08 and 0.03 µg/ml for EtG and EtS, respectively. The LOD in urine was 0.05 and 0.03 µg/ml for EtG and EtS, respectively, and 0.03 and 0.01 µg/ ml for serum EtG and EtS, respectively.
Between-and within-day precision and accuracy were always below 10% for both the analytes. Recovery values were within the range ±15%. No carry-over was observed.
EtG and EtS in serum
No EtG or EtS was detected in any serum sample obtained before the start of drinking experiments. One female volunteer did not provide blood samples because she had very small veins and it was too painful for her to be cannulated. We collected serum samples from a total of 18 volunteers (9:9 males: females). Table 1 . The average concentration-time profiles of EtG and EtS after the two alcohol doses are shown in Fig. 1A . The T max values for 4 and 8 units were significantly different, P = 0.001.
In almost all the volunteers, EtG was higher than EtS in all samples after administration of both 4 and 8 units. Only one female volunteer (T5F) had a higher EtS in all samples after 8 units. In this subject, EtS concentrations were similar to those of the other volunteers, while EtG values were 2.5-3 times lower than the mean values. After 4 units, she had very similar EtG and EtS concentrations.
The analytes were detectable for 6 h in all volunteers for both alcohol doses. In four females, the metabolites were detectable in serum for 10 h, but the concentrations were below the limit of quantification.
The EtG/EtS ratio increased up to 5-6 h after alcohol administration in all volunteers and in both drinking experiments. In the female with higher EtS concentrations, EtG/EtS decreased until 3 h after the administration of 8 units and then increased but always under the mean values.
For all the volunteers, the EtG/EtS ratios were always lower after the administration of 8 units (Fig. 1B ).
There were changes over time in the EtG/EtS profile for 4 and 8 units, P = 0.001. Furthermore, after the administration of both doses of alcohol, the EtG/EtS values for the first 4 h were significantly different (P = 0.001), considering the time intervals between 1-2 h, 2-3 h and 3-4 h. 
EtG and EtS in urine
No EtG or EtS was detected in any of the urine samples obtained before the start of drinking experiments. Urinary concentrations were normalized to the urine volume to obtain the milligram excreted per unit of time and also versus creatinine concentration. In Table 2 , the kinetic parameters measured for EtG and EtS are listed. The average concentration-time profiles of EtG and EtS after the two alcohol doses are shown in Fig. 2A . The T max values for 4 and 8 units were significantly different, P = 0.001.
Individual urinary EtG and EtS concentrations are presented in Table 3 .
The total median amount of EtG and EtS excreted after 4 units was 16.1 mg (IQR 8.2 mg) and 6.0 mg (IQR 3.1 mg; range: 9-24.6 and 2.7-9), respectively. After 8 units, the median was 57.6 mg (IQR 22.6 mg; range: 18.7-78) of EtG and 19.4 mg (IQR 5.9 mg; range: 14-31) of EtS were excreted. The analytes were detectable until 10 h and in some volunteers also at 24 h for the low dose. After 8 units, the metabolites were detectable until 24 h.
As in serum, urinary EtG was always higher than EtS in all volunteers with the only exception of T5F female volunteer who had EtS higher after 8 units and almost the same values of EtG and EtS after 4 units. In this volunteer, EtS concentrations were similar to the ones from the other volunteers while EtG was significantly lower. The total mass of EtG excreted was 18 mg versus a mean of 53 mg.
The EtG/EtS ratio increased up to 7-10 h after alcohol administration in all the volunteers and in both drinking experiments. The only exception was T5F where EtG/EtS values decreased until 6 h and then increased but always below the mean values. For all the volunteers the EtG/EtS ratios were always lower after 8 units (see Fig. 2B ).
As for serum analysis, there were changes over time in the EtG/EtS profile for 4 and 8 units, P = 0.001. Furthermore, after both alcohol doses, the EtG/EtS values for the first 5 h were significantly different (P < 0.001).
DISCUSSION
We measured EtG and EtS in urine and serum samples collected from 19 healthy volunteers administered two doses of alcohol. The study was designed to obtain a more accurate and comprehensive description of EtG and EtS concentration-time profiles in biological matrices.
Recently, three controlled drinking studies investigating the kinetics of EtG and EtS production in biological matrices have been published (Høiseth et al., 2007 (Høiseth et al., , 2010 Halter et al., 2008) . The advantages of our study are the analysis of EtG, EtS and their ratio in urine and serum samples after two doses of ethanol in a larger number of volunteers. More details of the comparison with these studies are shown in Table 4 . One challenge in our study was the fact that the volume of blood collected was less than in previously published data. This was done to minimize discomfort to the volunteers. Another possible limitation was that alcohol doses were given considering only the units of alcohol ingested (1 unit corresponds to 8 g of alcohol) and not by calculating the amount of ethanol consumed per kilogram of body weight. In the latter, the amount of alcohol in the body would be very similar in all the volunteers because of the Urinary concentrations were normalized to the urine volume to obtain the mg excreted per unit of time and also versus creatinine concentration. Data are presented as: median; interquartile range.
normalization against body weight. For this reason, in our study, the female volunteers had a mean amount of alcohol in the body almost 1.5 times higher than in males (0.88 ± 0.03 versus 0.63 ± 0.03 g/kg after 4 units; 1.76 ± 0.18 versus 1.27 ± 0.07 g/kg after 8 units). Even with these considerations, we decided to administer the volunteers consistent units of alcohol, because we wanted to obtain a more realistic drinking situation. In our results, we observed that gender did not have any effect on the concentration-time profiles for either EtG and EtS after 4 or 8 units.
The analysis of EtG and EtS together increases the sensitivity of the investigation because it is reported that EtG, but not EtS, can be produced after sampling if samples are infected with E. coli and contain ethanol formed by fermentation, for example, in samples from diabetics (Helander et al., 2007) . Thus, we recommend analysing EtG and EtS together to minimize false identification of alcohol consumption and possibly to identify alteration of metabolism of alcohol as described below.
EtG and EtS were always much higher in urine than in serum and they had a similar time course in both serum and urine in all the subjects. By comparing our results with those from other studies (Høiseth et al., 2007 (Høiseth et al., , 2010 Halter et al., 2008) , we obtained very similar EtG and EtS C max in serum, while urinary C max was slightly different (Table 4) . Because excretion of EtG and EtS is affected by water intake, we normalized the concentrations versus urine volume and creatinine values. We found better results in terms of less inter-variability, when concentrations were normalized using urine volume and values expressed as mass excreted per unit of time (Table 2) . In many volunteers, after the administration of both 4 and 8 units, the EtG and EtS urinary concentrations show a biphasic time-profile response. This is less obvious when the values are normalized against the urine volume and/or creatinine concentrations.
In our study, the T max values of EtG and EtS in urine and in serum after 4 units were lower than in the previous studies (Høiseth et al., 2007 (Høiseth et al., , 2010 Halter et al., 2008) ; the same situation was found after 8 units compared with T max after the high dose of alcohol administered by Høiseth et al. (2010; see also Table 4 ).
An interesting result we obtained was the rise of EtG and EtS T max in serum and urine between 4 and 8 units (see Tables 1 and 2 ). In Høiseth et al. (2010) , the authors found an increase in EtG T max between low and high doses of alcohol only in blood and not in urine. In our opinion, this finding could help to describe the kinetics of these metabolites better and improve the calculation and simulation of EtG and EtS concentration versus time using computer-assisted models (Droenner et al., 2002; Schmitt et al., 2010) . In this study, we also monitor the ratio between EtG and EtS and we found, in both drinking experiments, that the ratio always increased in serum and urine samples of all the volunteers as a function of time since alcohol was administered. The EtG/EtS values peaked in serum at 6 h after both 4 and 8 units, while in urine the maximum value was reached after 7 h. In urine samples after 8 units, the EtG/EtS values after 24 h were similar to those after 1 h (data not shown).
EtG/EtS values after 8 units were lower than after 4 units for all volunteers in serum and urine. Because sulphation is more saturable than glucuronidation at higher concentrations of substrate (Zamek-Gliszczynski et al., 2006) , we would expect a higher EtG/EtS ratio after 8 units. On the other hand, sulphation is a high-affinity and low-capacity metabolic reaction, which predominates at low substrate concentration. Considering the data obtained, we assumed that both pathways are not saturated over the range of alcohol administered in this study and sulphation works faster within this range. In fact, we measured (data not shown) the percentage increase in EtG and EtS between 4 and 8 units in serum and urine samples. We found that EtS increased~29% more than EtG in serum and 14% in urine. We also measured the ratio between serum and urine concentrations (serum/urine, urinary values normalized against urine volume) and we found that EtG and EtS have a similar time profile after both 4 and 8 units. This indicates that the excretion of the analytes is the same over the range of alcohol administration. This finding also suggests that the decrease in the EtG/EtS ratio after 8 units is not due to a differential clearance of the analytes, but it is related to the metabolic characteristics of sulphation and glucuronidation. We postulate that by increasing the dose of alcohol administered we should observe an opposite phenomenon with an increasing of the EtG/EtS ratio due to the saturation of sulphation.
This preliminary study was designed to obtain a comprehensive description of EtG and EtS concentration-time profiles in serum and urine. We observed a rise of EtG/EtS with time after administration, in both drinking experiments, mainly over the first 4 h. To our knowledge, this is the first study that has shown this EtG/EtS increase over time. Every 1 h until 6 h then 24 h, 48 h
Because this was a preliminary study, we have not been able to confirm whether EtG/EtS might be a useful marker of, or to describe a model to calculate time since, alcohol administration. These aspects should be the object of another study with a larger number of volunteers and more time-points sampled. Nevertheless, we suggest the monitoring of EtG/EtS in any future drinking experiment to evaluate its possible use in prediction models to determine the time of alcohol intake.
With the data obtained, we postulate that two or three consecutive urine or serum samples with increasing EtG/EtS might indicate recent drinking within the last 6-10 h depending on the biological specimen used for the investigation. Høiseth et al. (2007) suggested that two decreasing values of ethanol and EtG would exclude drinking during the last 3.5-5 h. EtG/ EtS might be additionally considered to evaluate its utility to possibly obtain a bigger time window to detect recent drinking. In urine samples after 8 units, we found that the EtG/EtS ratio after 24 h returns to the original value after 1 h since alcohol was administered. Because until 6-10 h (depending on the biological specimen: serum or urine) EtG/EtS rises, two or three consecutive decreasing values might suggest drinking before the previous 10 or even more hours. This is only a hypothesis because we did not collect any serum samples between 6 and 24 h and any urine samples between 10 and 24 h. This investigation will be the object of a future study aimed to collect more samples in the period between 7 and 24 h after the alcohol administration to observe the time course of the EtG/EtS ratio.
Considerable polymorphism in the genes coding for the enzymes uridine diphosphate-glucuronosyltransferases (UGT), mainly UGT1A1 and UGT2B7, and sulfotransferases (SULT) responsible for EtG and EtS formation is known (Schneider and Glatt, 2004; Foti and Fisher, 2005) . Thus, measuring EtG, EtS and their ratio over a few hours might readily indicate an altered metabolism related to genetic polymorphism of UGTs and SULTs thereby invalidating any kinetic model based on a normal population. A possible example might be the female volunteer (T5) who had higher urinary and serum EtS concentrations and decreasing values of EtG/EtS after the administration of 8 units perhaps caused by a polymorphism in her glucuronidation pathway reducing EtG formation. From our results, it seems that two or more consecutive urine or serum samples having decreasing EtG/EtS values and higher EtS are unlikely. This hypothesis needs to be confirmed by genetic analysis of this possible polymorphism in UGTs. Unfortunately, our ethical approval did not permit such analysis. Nevertheless, we report this finding since we believe that this needs consideration in any future study design.
In conclusion, this study described the concentration-time profiles of EtG and EtS in urine and serum in a more comprehensive way than before by obtaining new results regarding the absorption and excretion of the metabolites of these two alcohols.
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